IOL Chemicals and Pharmaceuticals Q2 Results FY27 Preview: Results Date, Expectations and the Numbers That Will Decide the September 2026 Quarter

Track the latest IOL Chemicals and Pharmaceuticals Ltd. share price on Univest. Investors and traders tracking IOL Chemicals and Pharmaceuticals Q2 results are already looking ahead to how the September 2026 quarter will shape up for the company, especially after the swings seen in the last five reported quarters. This preview lays out what is actually known, what the recent quarterly trend suggests, and what to watch before the IOL Chemicals and Pharmaceuticals Q2 results are formally announced by the company.

CMP Rs 199.58. Q1 FY27 (Jun26) revenue Rs 756 cr. Q1 FY27 net profit Rs 64 cr. PE 33.43. ROE 8.41%.

While no company can predict its own unreported numbers in advance, tracking the pattern of past quarters gives useful context for anyone following IOL Chemicals and Pharmaceuticals Q2 results closely. The sections below cover the likely results date, qualitative expectations, the immediate previous quarter, the year ago base quarter, the five quarter trend, and the valuation picture, all built only from data that has already been disclosed.

Open a free demat account with Univest and track this stock in real time

IOL Chemicals and Pharmaceuticals Q2 results: Likely Announcement Timeline

IOL Chemicals and Pharmaceuticals Ltd. has historically announced its quarterly numbers within four to six weeks of the quarter ending, a pattern visible across the Jun25, Sep25, Dec25, Mar26 and Jun26 (Q1 FY27) reporting cycles. Applying that same historical cadence to the September 2026 quarter, the IOL Chemicals and Pharmaceuticals Q2 results could plausibly be announced sometime in the last week of October or the first two weeks of November 2026, once the board formally approves the financials. No official date has been confirmed yet, so anyone tracking IOL Chemicals and Pharmaceuticals Q2 results should rely on the exchange filing calendar closer to the date rather than any fixed assumption.

IOL Chemicals and Pharmaceuticals Q2 results follows a quarter, Jun26, where both revenue and net profit hit five quarter highs, with revenue at Rs 756 crore and net profit at Rs 64 crore. The operating margin trend has been broadly improving since the Dec25 low of 9.83%, and that qualitative direction, rather than any specific forecast number, is the key input for expectations around IOL Chemicals and Pharmaceuticals Q2 results.

Previous Quarter: Q1 FY27 (Jun26) Performance

In the quarter right before the one covered by IOL Chemicals and Pharmaceuticals Q2 results, IOL Chemicals and Pharmaceuticals Ltd. reported revenue of Rs 756 crore, operating profit of Rs 103 crore, an operating margin of 13.62%, and net profit of Rs 64 crore. This Jun26 quarter forms the immediate sequential base against which the September 2026 quarter will eventually be compared once IOL Chemicals and Pharmaceuticals Q2 results are declared, and it sets the qualitative tone for near term expectations.

Also read – Nandani Creation Q2 Results FY27 Preview

Base Quarter for Comparison: Q2 FY26 (Sep25)

The year ago quarter that will anchor the year on year comparison for IOL Chemicals and Pharmaceuticals Q2 results is Sep25, when IOL Chemicals and Pharmaceuticals Ltd. posted revenue of Rs 568 crore, operating profit of Rs 57 crore, an operating margin of 10.04%, and net profit of Rs 30 crore. Whatever the company eventually reports for September 2026 will be measured against this Sep25 base, making it an important reference point ahead of IOL Chemicals and Pharmaceuticals Q2 results.

Track live stock prices and quarterly result updates with a free Univest account

Recent Trend Across the Last Five Quarters

The table below lays out the full five quarter history that anyone researching IOL Chemicals and Pharmaceuticals Q2 results should be aware of, from Jun25 (Q1 FY26) through Jun26 (Q1 FY27). Reviewing this trend line by line is a more reliable way to frame expectations for IOL Chemicals and Pharmaceuticals Q2 results than focusing on any one isolated quarter.

Quarter	Revenue	operating profit	Op. Margin	Net Profit
Jun25 (Q1 FY26)	Rs 552 cr	Rs 62 cr	11.23%	Rs 34 cr
Sep25 (Q2 FY26)	Rs 568 cr	Rs 57 cr	10.04%	Rs 30 cr
Dec25 (Q3 FY26)	Rs 580 cr	Rs 57 cr	9.83%	Rs 21 cr
Mar26 (Q4 FY26)	Rs 619 cr	Rs 92 cr	14.86%	Rs 53 cr
Jun26 (Q1 FY27)	Rs 756 cr	Rs 103 cr	13.62%	Rs 64 cr

Reading across this table, the pattern that stands out ahead of IOL Chemicals and Pharmaceuticals Q2 results is the sequence of movements in both the operating line and net profit, which have not always moved in the same direction from quarter to quarter.

Key Factors to Watch Ahead of IOL Chemicals and Pharmaceuticals Q2 results

Demand and pricing trends for key active pharmaceutical ingredients

This is one of the factors worth watching ahead of IOL Chemicals and Pharmaceuticals Q2 results, since it has a direct bearing on both revenue and margin trends for IOL Chemicals and Pharmaceuticals Ltd.

Raw material and solvent cost movements that affect the operating margin

This is one of the factors worth watching ahead of IOL Chemicals and Pharmaceuticals Q2 results, since it has a direct bearing on both revenue and margin trends for IOL Chemicals and Pharmaceuticals Ltd.

Capacity utilisation across manufacturing facilities

Also read – NACL Industries Q2 Results FY27 Preview

This is one of the factors worth watching ahead of IOL Chemicals and Pharmaceuticals Q2 results, since it has a direct bearing on both revenue and margin trends for IOL Chemicals and Pharmaceuticals Ltd.

Export demand trends in the pharma and chemicals segments

This is one of the factors worth watching ahead of IOL Chemicals and Pharmaceuticals Q2 results, since it has a direct bearing on both revenue and margin trends for IOL Chemicals and Pharmaceuticals Ltd.

Valuation Snapshot

As of the current market price of Rs 199.58, IOL Chemicals and Pharmaceuticals Ltd. trades at a price to earnings (PE) ratio of 33.43 and a price to book (PB) ratio of 3.26, against a book value of Rs 61.3 per share. Return on equity (ROE) stands at 8.41%, the debt to equity ratio is 0.08, and the dividend yield is 0.51%. The stock has a total market capitalisation of Rs 5900 crore, with a 52 week high of Rs 219.04 and a 52 week low of Rs 67.19. These are the valuation metrics investors following IOL Chemicals and Pharmaceuticals Q2 results typically reference when weighing the current price against historical earnings.

Open your free Univest demat account before the next results season

What to Watch Going Into IOL Chemicals and Pharmaceuticals Q2 results

Beyond the headline revenue and profit figures, readers should watch the operating margin trajectory, any commentary from management on demand or cost conditions, and whether the 13.62% operating margin recorded in Jun26 holds, improves, or slips further once IOL Chemicals and Pharmaceuticals Q2 results are out. The 50 day moving average of Rs 172.08 and the 200 day moving average of Rs 113.45 are also useful technical reference points that traders often watch around a results announcement, alongside the current RSI of 52.75.

Conclusion

IOL Chemicals and Pharmaceuticals Q2 results are not due for a few more weeks, and no specific number for the September 2026 quarter can be responsibly estimated today. What can be said, based purely on historical, publicly disclosed data, is that IOL Chemicals and Pharmaceuticals Ltd. has shown a distinct pattern across its last five quarters, and that pattern, along with the qualitative factors outlined above, is the most reasonable lens through which to approach IOL Chemicals and Pharmaceuticals Q2 results once they are formally announced. This article does not offer any buy, sell or hold view, and readers should treat it purely as a factual data based preview.

Disclaimer: Univest Securities Private Limited is a SEBI-registered Research Analyst (Registration No. INH000013776). This article is for educational and informational purposes only and does not constitute investment advice, a recommendation, or a solicitation to buy or sell any security. Figures cited are historical, publicly disclosed quarterly financials and current market data; no specific Q2 FY27 results, estimates, or forecasts are implied. Please consult a SEBI-registered investment adviser and verify data independently before making any investment decision.

FAQs

When will IOL Chemicals and Pharmaceuticals Q2 results be announced?

Ans. Based on the company's historical reporting calendar, IOL Chemicals and Pharmaceuticals Ltd. typically announces quarterly numbers within four to six weeks of the quarter closing. Applying that pattern, IOL Chemicals and Pharmaceuticals Q2 results could be expected around late October to mid November 2026, though the exact date will only be confirmed through an official exchange filing.

What was the net profit in the previous quarter before IOL Chemicals and Pharmaceuticals Q2 results?

Ans. In the Jun26 quarter (Q1 FY27), IOL Chemicals and Pharmaceuticals Ltd. reported a net profit of Rs 64 crore on revenue of Rs 756 crore, with an operating margin of 13.62%. This is the most recent reported quarter available ahead of IOL Chemicals and Pharmaceuticals Q2 results.

What is the base quarter used for year on year comparison in IOL Chemicals and Pharmaceuticals Q2 results?

Ans. The Sep25 quarter (Q2 FY26) is the base quarter that the September 2026 quarter will eventually be compared against once IOL Chemicals and Pharmaceuticals Q2 results are declared. In Sep25, IOL Chemicals and Pharmaceuticals Ltd. reported revenue of Rs 568 crore and net profit of Rs 30 crore.

What is the current valuation of the stock ahead of IOL Chemicals and Pharmaceuticals Q2 results?

Ans. As of the latest available data, IOL Chemicals and Pharmaceuticals Ltd. trades at a PE ratio of 33.43, a PB ratio of 3.26, and an ROE of 8.41%, with a market capitalisation of Rs 5900 crore. These figures are current market data and are not forecasts for IOL Chemicals and Pharmaceuticals Q2 results.